Ramiro Sanchez
CIK 1830326 · Chief Medical Officer · last filed 2026-06-10
Ramiro Sanchez is a Chief Medical Officer who has filed 16 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing, for RAPP, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
16
-$1.57M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RAPP | Director | — | $38.40 | — | $0 | 3 | 2026-06-10 |
| ANRO | Director | — | $21.47 | — | $0 | 3 | 2026-05-14 |
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Chief Medical Officer | 24,673 | $44.96 | $1.11M | -$1.57M | 7 | 2024-01-23 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Chief Medical Officer | — | $18.07 | — | $0 | 2 | 2021-02-05 |
Recent Filings
16 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2026-05-14 | ANRO | Grant (A) | — | $0 | EDGAR |
| 2026-01-06 | ANRO | Grant (A) | — | $0 | EDGAR |
| 2025-08-14 | ANRO | Grant (A) | — | $0 | EDGAR |
| 2025-06-18 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2024-11-07 | RAPP | Grant (A) | — | $0 | EDGAR |
| 2024-08-05 | — | Disp (D) | −14,673 | $0 | |
| 2024-01-23 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-12-28 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | — | -$389.7K | EDGAR |
| 2023-12-21 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | +14,673 | -$420.5K | EDGAR |